PTGS2 and obesity disorder: For this reason, great efforts are being made for disrupting the obesity-cancer link by targeting inflammation with omega-3 fatty acids, non-steroidal anti-inflammatory drugs, monoclonal antibodies against specific cytokines, selective COX-2 inhibitors or polyphenolic compounds.